来自Garcinia mangostana的细胞毒性代谢物
Abdullah I R Alanazi1, Hossam M Abdallah1,2, Hagar M Mohamed3,4
1Department of Natural Products and Alternative Medicine, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Journal of pharmacy & bioallied sciences
|August 27, 2025
概括
作为抗癌剂的 Garcinia mangostana 化合物是有前途的. 在实验室中,Garcinone D和alpha- mangostin对卵巢,肝脏和结直肠癌细胞系具有显著的细胞毒性作用.
科学领域:
- 植物化学
- 药理学
- 癌症研究
背景情况:
- 在东南亚医药中用于感染和伤口的传统使用.
- 主要的生物活性成分被确定为桑和化合物.
- 桃花及其代谢物具有多种生物活性.
研究的目的:
- 从Garcinia mangostana pericarp中分离和识别生物活性化合物
- 评估隔离化合物的体内细胞毒性对各种癌细胞系的影响.
- 确定潜在的化合物用于抗癌药物开发.
主要方法:
- 用甲醇提取Garcinia mangostana pericarp,然后进行溶剂分离和染色学净化.
- 使用NMR和文献数据分离和鉴定了六种化合物:α-曼戈斯,β-曼戈斯,加尔坦,加尔辛C,加尔辛D和阿斯蒂尔宾.
- 使用硫胺B (SRB) 测定对卵巢 (SKOV- 3),肝脏 (HepG- 2) 和结直肠 (HCT- 116) 癌细胞系进行体外细胞毒性评估,用多克索鲁比作为阳性对照.
主要成果:
- 所有分离的化合物都表现出不同程度的细胞毒性.
- Garcinone D对SKOV-3细胞具有显著的细胞毒性 (IC50 27. 27 ± 2. 41μM).
- 阿尔法-曼戈斯和β-曼戈斯对HepG-2细胞具有细胞毒性 (IC50分别为28. 1±1.1μM和31. 9±10. 7μM).
- 贝塔- 曼戈斯和加辛D对HCT-116细胞具有细胞毒性作用 (IC50分别为56. 1±2.5μM和44. 3±2.5μM).
结论:
- 加尔西尼亚曼戈斯塔纳周围植物具有显著的细胞毒性.
- Garcinone D和alpha-mangostin被认为是进一步开发抗癌药物的有希望的化合物.
- 这项研究证实了Garcinia mangostana衍生品在癌症治疗研究中的潜力.
更多相关视频
14:57Spectrophotometric Screening for Potential Inhibitors of Cytosolic Glutathione S-Transferases
Published on: October 10, 2020
14.6K
08:22Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants
Published on: December 22, 2023
692
相关概念视频
Enhanced Elimination of Poison
577
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
577
Mutagenicity and Carcinogenicity
1.4K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.4K
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Necrosis
4.8K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
